0001564590-22-012055 Sample Contracts

AMENDMENT NO. 1

Molecular Templates, Inc. • March 29th, 2022 • Pharmaceutical preparations

• Company
  Molecular Templates, Inc.
• Filed
  March 29th, 2022
• Industry
  Pharmaceutical preparations

This Amendment No.1 (this “Amendment”) is effective as of December 2, 2021 (the “Amendment Effective Date”) and is entered into by and between Molecular Templates, Inc. (“MTEM”) and Bristol-Myers Squibb Company (“BMS”). MTEM and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.